{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Systemic+Allergic+Reaction", "query": { "condition": "Systemic Allergic Reaction" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 71, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Systemic+Allergic+Reaction&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T21:48:31.406Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02176070", "title": "Reproductive Health in Men and Women With Vasculitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Giant Cell Arteritis", "Takayasu's Arteritis", "Polyarteritis Nodosa", "Wegener's Granulomatosis", "Microscopic Polyangiitis", "Churg-Strauss Syndrome", "Behcet's Disease", "Kawasaki Disease", "Henoch-schoenlein Purpura", "Vasculitis, Central Nervous System", "Drug-induced Necrotizing Vasculitis" ], "interventions": [], "intervention_types": [], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 467, "start_date": "2011-02", "completion_date": "2012-03", "has_results": false, "last_update_posted_date": "2014-06-26", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02176070" }, { "nct_id": "NCT07290803", "title": "This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atopic Dermatitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1000, "start_date": "2025-11-17", "completion_date": "2034-01-30", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Gilbert, Arizona + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07290803" }, { "nct_id": "NCT05491447", "title": "A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "BMX-010", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMimetix JV, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 103, "start_date": "2023-01-08", "completion_date": "2024-04-15", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Bryant, Arkansas • Fort Smith, Arkansas + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bryant", "state": "Arkansas" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "Inglewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05491447" }, { "nct_id": "NCT03083730", "title": "Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Narrow band UVB treatment (NB-UVB)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Rockefeller University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2017-07-19", "completion_date": "2020-02-24", "has_results": false, "last_update_posted_date": "2020-02-26", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03083730" }, { "nct_id": "NCT07532564", "title": "Risk Factors, Costs, and Impacts of ED Boarding", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke (CVA) or TIA", "Diabetes", "Asthma (Diagnosis)", "COPD (Chronic Obstructive Pulmonary Disease)", "Sepsis", "Hypertension", "Heart Failure", "Pneumonia", "Urinary Tract Infection (Diagnosis)", "Chest Pain", "Psychiatric Disorder", "Sickle Cell Disease (SCD)" ], "interventions": [], "intervention_types": [], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30486, "start_date": "2022-01-01", "completion_date": "2025-12-31", "has_results": true, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07532564" }, { "nct_id": "NCT01931644", "title": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "All Diagnosed Health Conditions", "ADD/ADHD", "Alopecia Areata", "Ankylosing Spondylitis", "Asthma", "Atopic Dermatitis Eczema", "Beta Thalassemia", "Bipolar Disorder", "Breast Cancer", "Celiac Disease", "Cervical Cancer", "Chronic Inflammatory Demyelinating Polyneuropathy", "Chronic Kidney Diseases", "Chronic Obstructive Pulmonary Disease", "Colon Cancer", "Colorectal Cancer", "Crohn's Disease", "Cystic Fibrosis", "Depression", "Diabetes Mellitus", "Duchenne Muscular Dystrophy", "Endometriosis", "Epilepsy", "Facioscapulohumeral Muscular Dystrophy", "G6PD Deficiency", "General Anxiety Disorder", "Hepatitis B", "Hereditary Hemorrhagic Telangiectasia", "HIV/AIDS", "Human Papilloma Virus", "Huntington's Disease", "Idiopathic Thrombocytopenic Purpura", "Insomnia", "Kidney Cancer", "Leukemia", "Lung Cancer", "Lupus Nephritis", "Lymphoma", "Melanoma", "Multiple Myeloma", "Multiple Sclerosis", "Myositis", "Myotonic Dystrophy", "Ovarian Cancer", "Pancreatic Cancer", "Parkinson's Disease", "Polycystic Kidney Diseases", "Prostate Cancer", "Psoriasis", "Psoriatic Arthritis", "Rosacea", "Scleroderma", "Sickle Cell Anemia", "Sickle Cell Trait", "Sjogren's Syndrome", "Skin Cancer", "Spinal Muscular Atrophy", "Systemic Lupus Erythematosus", "Thrombotic Thrombocytopenic Purpura", "Trisomy 21", "Ulcerative Colitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 17667, "start_date": "2013-07", "completion_date": "2024-04", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931644" }, { "nct_id": "NCT03562377", "title": "Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Tralokinumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Tdap vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "54 Years", "sex": "ALL", "summary": "18 Years to 54 Years" }, "enrollment_count": 215, "start_date": "2018-07-13", "completion_date": "2019-11-22", "has_results": true, "last_update_posted_date": "2025-03-11", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 39, "location_summary": "Fort Smith, Arkansas • Bakersfield, California • Beverly Hills, California + 33 more", "locations": [ { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03562377" }, { "nct_id": "NCT05121753", "title": "Infant Formula Feeding and Necrotizing Enterocolitis in Newborns", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Necrotizing Enterocolitis", "Necrotizing Enterocolitis of Newborn", "Sepsis Newborn", "Cows Milk Allergy" ], "interventions": [ { "name": "Survey investigating Infant formula feeding in newborns", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Neuroganics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "2 Years", "sex": "ALL", "summary": "1 Day to 2 Years" }, "enrollment_count": 1000, "start_date": "2022-02-15", "completion_date": "2024-01-15", "has_results": false, "last_update_posted_date": "2022-02-08", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 1, "location_summary": "Northglenn, Colorado", "locations": [ { "city": "Northglenn", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05121753" }, { "nct_id": "NCT00103623", "title": "The Plenaxis® Experience Study", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Plenaxis", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PRAECIS Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 2000, "start_date": "2004-06", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2006-09-19", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Goodyear, Arizona • Phoenix, Arizona + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00103623" }, { "nct_id": "NCT06136767", "title": "Registry for Systemic Eczema Treatments", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atopic Dermatitis" ], "interventions": [], "intervention_types": [], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "26 Years", "sex": "ALL", "summary": "1 Year to 26 Years" }, "enrollment_count": 400, "start_date": "2024-01-17", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-07-22T21:48:31.406Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06136767" } ] }